Description

---

"AI Pharma: Artificial Intelligence in Drug Discovery and Development" is a comprehensive exploration of how artificial intelligence is reshaping the pharmaceutical industry. It reveals how machine learning, deep learning, and other advanced technologies are revolutionizing drug discovery and development. The book meticulously charts the evolution of AI's role, starting from the surge in data collection and processing to the latest breakthroughs in predictive modeling.

It unveils AI's transformative impact on research and development, delving into how AI tools streamline target identification, molecule generation, and clinical trials, leading to faster, more accurate results. Key industry experts share insights on the challenges of navigating the vast amount of data produced, stressing the importance of data cleaning, curation, and ethical considerations in collection.

Case studies highlight how startups and leading companies use AI algorithms for deep learning in drug development, identifying disease targets and generating new compounds with unprecedented precision. The book emphasizes practical applications, like predictive models for toxicity and safety in preclinical trials and patient recruitment optimization in clinical trials.

Additionally, it tackles the intersection of AI with emerging technologies like the Internet of Medical Things (IoMT) and blockchain, showcasing how these complement AI in securing data and enhancing pharmaceutical supply chains. Readers will gain a deep understanding of the regulatory landscape, exploring FDA guidelines and global regulations that shape AI adoption.

Interwoven throughout are the voices of thought leaders who address legal and ethical challenges, highlight the significance of partnerships, and stress the need for transparent and trustworthy AI models. They emphasize cross-disciplinary collaboration and tailored training strategies to cultivate AI talent that meets the growing needs of pharma. By examining the future of deep learning, computational research, and explainable AI, the book provides a strategic roadmap that researchers, policymakers, and developers can follow.

Ultimately, this book is not only a roadmap but also a clarion call, urging stakeholders to build collaborative ecosystems that harness AI's potential for innovative pharmaceutical research and development. Through a rich, detailed narrative, readers are guided to understand the profound implications and exciting opportunities that await in this AI-driven pharmaceutical landscape.